中聯重科(000157.SZ):從美國直接進口零部件的金額極低
格隆匯5月9日丨中聯重科(000157.SZ)在投資者互動平臺表示,公司從美國直接進口零部件的金額極低,2024年約爲1600萬人民幣,佔公司該年營業成本比例低於0.05%。 一直以來,公司堅定以科技創新着力打造穩定、可靠、具有全球競爭力的國產供應鏈體系:公司持續投入高強度研發,近三年研發投入106.40億元,研發投入強度約8%。依靠內生與外延的力量,持續創新迭代核心技術,不斷突破國外領先技術,加快了進口零部件國產替代進程,增強關鍵零部件的自主研發力度,零部件原裝進口金額佔比已經很少。公司不斷完善自身的供應鏈體系,尤其是新一輪科技革命中,公司已經形成一整套新能源領域關鍵零部件產業體系,包括新能源動力、傳動器、控制器、液壓閥、油缸等等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.